The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions

被引:0
作者
Vasiliki Pitiriga
Georgia Vrioni
George Saroglou
Athanasios Tsakris
机构
[1] University of Athens,Department of Microbiology, Medical School
[2] Metropolitan General Hospital,undefined
来源
Advances in Therapy | 2017年 / 34卷
关键词
Antimicrobial stewardship program; Feedback; Infection control; Infectious diseases; Preauthorization; Prospective audit; Quinolones; Resistance; Restrictive policies;
D O I
暂无
中图分类号
学科分类号
摘要
Quinolones are among the most commonly prescribed antibiotics worldwide. A clear relationship has been demonstrated between excessive quinolone use and the steady increase in the incidence of quinolone-resistant bacterial pathogens, both in hospital and community sites. In addition, exposure to quinolones has been associated with colonization and infection with healthcare-associated pathogens such as methicillin-resistant Staphylococcus aureus and Clostridium difficile in hospitalized patients. Therefore, the management of quinolone prescribing in hospitals through antibiotic stewardship programs is considered crucial. Although suggestions have been made by previous studies on the positive impact of stewardship programs concerning the emergence and spread of multidrug-resistant bacteria at hospital level, the association of quinolone-targeted interventions with reduction of quinolone resistance is vague. The purpose of this article was to evaluate the impact of stewardship interventions on quinolone resistance rates and healthcare-associated infections, through a literature review using systematic methods to identify and select the appropriate studies. Recommendations for improvements in quinolone-targeted stewardship programs are also proposed. Efforts in battling quinolone resistance should combine various interventions such as restriction formulary policies, prospective audits with feedback to prescribers, infection prevention and control measures, prompt detection of low-level resistance, educational programs, and guidelines for optimal quinolone usage. However, the effectiveness of such strategies should be assessed by properly designed and conducted clinical trials. Finally, novel approaches in diagnostic stewardship for rapidly detecting bacterial resistance, including PCR-based techniques, mass spectrometry, microarrays, and whole-genome sequencing as well as the prompt investigation on the clonality of quinolone-resistant strains, will strengthen our ability to personalize quinolone prescribing to individual patients.
引用
收藏
页码:854 / 865
页数:11
相关论文
共 167 条
  • [1] Goossens H(2007)Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries Clin Infect Dis 44 1091-1095
  • [2] Ferech M(2005)Antimicrobial safety: focus on fluoroquinolones Clin Infect Dis 15 S144-S157
  • [3] Coenen S(2003)Fluoroquinolones and the risk for methicillin-resistant Emerg Infect Dis 9 1415-1422
  • [4] Stephens P(2008) in hospitalized patients Clin Infect Dis 46 S19-S31
  • [5] Owens RC(2008)Antimicrobial-associated risk factors for Antimicrob Agents Chemother 52 3795-3800
  • [6] Ambrose PG(2007) infection Am J Infect Control 35 S165-S193
  • [7] Weber SG(2007)Fluoroquinolones enhances the mutation frequency for meropenem-selected carbapenem resistance in Clin Infect Dis 44 159-177
  • [8] Gold HS(2004), but use of the high-potency drug doripenem inhibits mutant formation J Antimicrob Chemother 53 853-859
  • [9] Hooper DC(2006)Management of multidrug-resistant organisms in health care settings, 2006 Clin Infect Dis 42 778-784
  • [10] Karchmer AW(2006)Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Infect Control Hosp Epidemiol 27 155-169